Development Programs. Within 90 days of the completion of the Research Program, DYAX and EPIX shall discuss and agree upon the following development programs for the Imaging Field: For the optimization of the lead Thrombus Ligands suitable for magnetic resonance imaging and preclinical and clinical development of MRI Products exclusively by EPIX ("MRI Development Program"); and for the optimization of lead Thrombus Ligands suitable for radiopharmaceutical imaging and preclinical and clinical development of RadioPharma Products exclusively by DYAX ("RadioPharma Development Program"). EPIX will have responsibility for the costs and decisions of the MRI Development Program, and DYAX will have responsibility for the costs and decisions of the RadioPharma Development Program. Each party agrees to use all commercially reasonable efforts to diligently develop MRI Products and RadioPharma Products, as applicable, and to provide the Steering Committee with semi-annual reports on the status and results of their respective development programs, which each party shall be entitled to use in the development and commercialization of products pursuant to this Agreement.
Appears in 3 contracts
Sources: Collaboration Agreement (Epix Medical Inc), Collaboration Agreement (Dyax Corp), Collaboration Agreement (Dyax Corp)